Complicated Intra-Abdominal Infections (cIAIs) Completed Phase 3 Trials for Ceftolozane (DB09050)

Also known as: Complicated Intra-abdominal Infection (cIAI) / Complicated Intra-Abdominal Infections, cIAIs / Complicated Intraabdominal Infections / Intra Abdominal Infections Complicated / Complicated Intra Abdominal Infections / Complicated Intra-Abdominal Infection / Complicated Intra-Abdominal Infections / Abdominal infection / Infectious disease of abdomen (disorder) / Intra-abdominal infection / Intraabdominal Infections

IndicationStatusPhase
DBCOND0079243 (Complicated Intra-Abdominal Infections (cIAIs))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02739997Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Complicated Intra-abdominal Infection (MK-7625A-013)Treatment
NCT03830333Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)Treatment